Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net earnings	$ 94,892	$ 81,895
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	37,077	40,878
Stock compensation expense	12,787	12,267
Deferred income taxes	(1,918)	(2,422)
Provision for doubtful accounts	238	1
Unrealized gain on foreign currency transactions and deferred compensation	(730)	(778)
Asset impairment and loss on disposal of assets	1,479	6,858
Change in fair value of contingent consideration liability	(91)	(9,900)
Changes in assets and liabilities
Accounts receivable	5,220	2,606
Inventories	(8,738)	2,545
Prepaid expenses and other current assets	1,199	(2,703)
Accounts payable and accrued expenses	(9,734)	(6,429)
Income taxes	(3,110)	(7,742)
Other	1,111	(721)
Net cash provided by operating activities	129,682	116,355
Cash flows from investing activities:
Capital expenditures and intangible assets acquired	(22,936)	(26,177)
Cash paid for acquisitions, net of cash acquired	0	(1,252)
Proceeds from sale of assets	272	1,881
Proceeds from settlement of net investment hedge	0	2,740
Investment in affiliates	(113)	(140)
Net cash used in investing activities	(22,777)	(22,948)
Cash flows from financing activities:
Proceeds from revolving loan	26,000	18,000
Principal payments on revolving loan	(108,569)	(78,000)
Principal payments on finance lease	(169)	(166)
Proceeds from stock options exercised	15,084	3,888
Dividends paid	(25,572)	(22,872)
Repurchases of common stock	(5,376)	(4,025)
Net cash used in financing activities	(98,602)	(83,175)
Effect of exchange rate changes on cash	944	160
Increase in cash and cash equivalents	9,247	10,392
Cash and cash equivalents beginning of period	64,447	66,560
Cash and cash equivalents end of period	$ 73,694	$ 76,952